Does Wegovy Cause Acid Reflux?
Wegovy (semaglutide), a GLP-1 receptor agonist for weight loss, lists gastrointestinal side effects in its prescribing information, including nausea, vomiting, diarrhea, and abdominal pain. Acid reflux, or gastroesophageal reflux disease (GERD)-like symptoms such as heartburn, is not a primary listed effect but has been reported by users and in post-marketing data.[1][2]
What Do Clinical Trials Show?
In the STEP trials for semaglutide (Wegovy's active ingredient), upper GI adverse events occurred in about 20-25% of patients, mainly nausea (up to 44% in higher doses). Dyspepsia (indigestion) was reported in 5-10%, which can overlap with reflux symptoms. Heartburn or reflux wasn't broken out separately but falls under broader GI complaints. Trials noted these effects peak early and often resolve.[3][4]
User Reports and Real-World Experience
On platforms like Drugs.com and patient forums, around 5-10% of Wegovy reviewers mention heartburn, acid reflux, or GERD worsening. Some describe it as new-onset reflux triggered by the drug's slowing of gastric emptying, which may increase stomach pressure and relax the lower esophageal sphincter.[5][6] Reddit threads and social media echo this, with users linking it to higher doses (1.7mg or 2.4mg weekly).
Why Might It Happen?
Semaglutide delays gastric emptying, potentially trapping food and acid in the stomach longer, mimicking reflux. This mechanism is common to GLP-1 drugs like Ozempic (same ingredient). Obesity itself raises GERD risk, so weight loss might eventually help, but initial use can exacerbate it.[7]
How Common Is It Compared to Other Weight Loss Drugs?
Less frequent than nausea but more noted than with older drugs like phentermine. Vs. tirzepatide (Mounjaro/Zepbound), semaglutide users report similar GI issues, though tirzepatide may cause less reflux per anecdotal data. In head-to-head studies, both classes hit GI tolerability hard.[8]
What Can Patients Do About It?
- Take on empty stomach, stay upright post-dose.
- Use antacids (e.g., Tums), PPIs (e.g., omeprazole), or H2 blockers if needed—safe with Wegovy per labels.
- Dose titration slowly; symptoms often fade after 4-8 weeks.
- Consult a doctor if severe; rare cases link to gastroparesis.[2][9]
When to Worry or Stop
Reflux alone rarely requires stopping Wegovy (discontinuation rate for GI effects ~5-7%). Seek care for persistent vomiting, severe pain, or weight loss stalling, as these signal rarer issues like pancreatitis or gallbladder problems.[1]
Sources:
[1] Wegovy Prescribing Information (Novo Nordisk)
[2] FDA Adverse Event Reporting System (FAERS) data on semaglutide
[3] NEJM STEP 1 Trial (2021)
[4] STEP 2 Trial (2021)
[5] Drugs.com Wegovy Reviews
[6] WebMD Semaglutide User Ratings
[7] Gastroenterology Review on GLP-1s and GERD (2023)
[8] SURMOUNT-1 Trial vs. Semaglutide (2023)
[9] Mayo Clinic GLP-1 Side Effect Management